TABLE 3.
Sample # | IBD Treatment Naïve |
Age at collection |
Gender | Hispanic/non | Race | Gross sigmoid disease |
Paris Disease Location |
PUCAI (on day of sample collection) |
---|---|---|---|---|---|---|---|---|
Active UC | ||||||||
1 | No | 23 | Female | Non-Hispanic | White | Yes (mild) | E4 | 0 |
2 | No | 12 | Female | Non-Hispanic | White | yes | E4 | 30 |
3 | No | 21 | Male | non-Hispanic | White | yes | E4 | 60 |
4 | No | 10 | Female | Non-Hispanic | White/Asian Indian |
yes | E4 | 25 |
5 | No | 11 | Female | Hispanic | White | Yes-mild chronic | E4 | Unable to ascertain |
6 | Yes | 17 | Male | Non-Hispanic | White | Yes | E3 | 35 |
7 | Yes | 13 | Female | Non-Hispanic | White | Yes | E4 | 45 |
8 | No | 16 | Male | Non-Hispanic | White/Asian | yes | E4 | 40 |
Inactive UC | ||||||||
1 | No | 19 | Male | Non-Hispanic | White | No | E3 | 0 |
2 | No | 17 | Male | Non-Hispanic | White | Yes (mild) | E4 | 0 |
3 | No | 22 | Female | Non-Hispanic | White | No | E4 | 15 |
4 | No | 21 | Male | Non-Hispanic | White | No | E3 | 0 |
5 | No | 22 | Female | Non-Hispanic | White | No | E4 | 0 |
6 | No | 25 | Male | Non-Hispanic | White | No | E4 | 0 |
7 | Yes | 14 | Female | Non-Hispanic | White | No | E4 | 0 |
8 | No | 17 | Male | Non-Hispanic | White | No | E4 | 5 |